BEAM Beam Therapeutics Inc.

BEAM Beam Therapeutics Inc.

Healthcare · Biotechnology

Market read

Scan convergence 1 scan as of 2026-08-14 1 neutral converging

POC $26.46 · VWAP $26.83 · +1.0% vs 12m avg buyer

pullback vol: compressedchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

BEAM Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist BEAM belongs to, members best 30-day change first — BEAM highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@biotech-scan

Next earnings BEAM reports in 77 days Nov 3

Last report May 6

Reported the quarter ending 2026-03-31: revenue $32M, diluted EPS $-0.91, net income $-94M (SEC filing). Across the print the stock moved +8.9% (close before → first close after).

full note →

Against street estimates

How BEAM's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 11 quarters · newest report Aug 4 · projection Aug 17

Result
Aug 4 -1.13-1.18-4.8%Miss
May 7 -1.01-0.91+10.1%Beat
Feb 24 -1.122.33+309.0%Beat
Nov 4 '25 -1.01-1.10-8.9%Miss
Aug 5 '25 -1.09-1.00+8.4%Beat
May 6 '25 -1.17-1.24-5.9%Miss
Feb 25 '25 -1.22-1.09+10.3%Beat
Nov 5 '24 -1.18-1.17+0.9%In line

News (last pull)

Headlines about BEAM from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 42 days ago · Jul 7

Types
Aug 4 Catalyst BEAM earnings
May 6 Catalyst BEAM earnings